Loading organizations...
§ Private Profile · Seoul, Seoul-t'ukpyolsi, South Korea
AI-powered healthcare technology platform developing personalized diabetes management solutions for individuals, doctors, and coaches.
GlucoFit is a Seoul, South Korea-based healthcare technology startup that develops an artificial intelligence-powered platform for personalized diabetes management and data-driven therapy solutions. The company provides a comprehensive digital ecosystem that integrates advanced health analytics to deliver individualized treatment plans, continuous patient monitoring, and actionable medical insights. Operating from the Teheran-ro corridor in the Yeoksam-dong neighborhood of Gangnam-gu, the platform serves a diverse healthcare network that includes individuals with diabetes, medical doctors, and specialized diabetes coaches. The South Korean seed-stage enterprise currently operates on a subscription and usage-based business model to monetize its proprietary healthcare software infrastructure. To support its ongoing clinical expansion and technological development, the organization has successfully secured $900,000 in seed venture capital funding. GlucoFit was officially founded in 2022 by chief executive officer Inka Benthin alongside chief technology officer Dr. Matthias Ohliger.
GlucoFit has raised $1.0M across 1 funding round.
GlucoFit has raised $1.0M in total across 1 funding round.
GlucoFit has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Pre-Series A in February 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 27, 2024 | $1M Seed Plus | Jong IL Yoon | Capstone Partners, D.camp, Infobank | Announced |
GlucoFit has raised $1.0M in total across 1 funding round.
GlucoFit's investors include Jong-Il Yoon, Capstone Partners, D.CAMP, Infobank.